AFL Share Price Performance
US$111.17
-0.44 (-0.39%)
2.6% overvalued intrinsic discount
US$108.31
Fair Value
Price US$111.17
AnalystConsensusTarget US$108.31
Fair ValueUS$108.31
Share PriceUS$111.17
2.6% overvalued intrinsic discount
Aflac Incorporated Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 63 Fair Values set on narratives written by author
AFL Community Narratives
AN
Fair Value US$108.31 3.3% overvalued intrinsic discount
Custom Cancer Insurance And Digital Underwriting Will Drive Future Expansion
1users have liked this narrative
0users have commented on this narrative
30users have followed this narrative
Aflac Incorporated Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 04, 2025
- Earnings per share (EPS)
- 4.56
- Gross Margin
- 41.39%
- Net Profit Margin
- 15.32%
- Debt/Equity Ratio
- 54.7%
Aflac Incorporated Competitors
Snowflake Analysis
About AFL
- Founded
- 1955
- Employees
- 12694
- CEO
- WebsiteView website
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is based in Columbus, Georgia.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
U.S. Market Performance
- 7 Days: 0.3%
- 3 Months: 8.5%
- 1 Year: 17.3%
- Year to Date: 15.0%
The market has stayed flat over the 7 days. As for the longer term, the market has risen 17% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›